Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer.

Kenji NakatsumaNeiko OzasaMikiko OhnoHiroshi IshiguroManabu MinamiEiichiro NishiMasakazu ToiKoh OnoTakeshi Kimura

Published in: Journal of cardiology (2024)

Approximately two-thirds of the Japanese patients in this study experienced CTRCD, which was frequently observed at 3 or 6 months post-AC. However, all patients with CTRCD were diagnosed with mild asymptomatic CTRCD. Although, these patients were diagnosed with mild asymptomatic CTRCD, careful long-term follow-up will be required.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
oxidative stress
heart failure
patient reported outcomes
squamous cell carcinoma
radiation therapy
atrial fibrillation